Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic

American Journal of Respiratory and Critical Care Medicine

Volumn 166, Issue 7, 2002, Pages 983-987

  Armstrong, David S ^a,b,c,d   Nixon, Gillian M ^a,b,c,d   Carzino, Rosemary ^a,b,c,d   Bigham, Andrea ^a,b,c,d   Carlin, John B ^a,b,c,d   Robins Browne, Roy M ^a,b,c,d   Grimwood, Keith ^a,b,c,d  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cross infection; Cystic fibrosis; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; TIMENTIN; TOBRAMYCIN;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CHILD; CLONE; CROSS INFECTION; CYSTIC FIBROSIS; DISEASE EXACERBATION; FEMALE; GENOTYPE; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PEDIATRICS; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; SPUTUM CULTURE;

ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; CLONE CELLS; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; DNA FINGERPRINTING; FEMALE; HUMANS; MALE; PSEUDOMONAS AERUGINOSA; SPUTUM; VICTORIA;

EID: 0036796762     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200204-269OC     Document Type: Article

References (35)

1. Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infections. J Clin Epidemiol 1995;48:1041-1049.
2. Romling U, Fiedler B, Boßhammer J, Grouthues D, Greipel J, von der Hardt H, Tummler B. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J Infect Dis 1994;170:1616-1621.
3. Mahenthiralingham E, Campbell ME, Foster J, Lam JS, Speert DP. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J Clin Microbiol 1996;34:1129-1135.
4. Grouthes D, Kopman U, von der Hardt H, Tummler B. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol 1988;26:1973-1977.
5. Wolz C, Kiosz G, Ogle JW, Vasil ML, Schaad U, Botzenhart K, Doring G. Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis: use of a DNA probe. Epidemiol Infect 1989;102:205-214.
6. Speert DP, Campbell ME. Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis. J Hosp Infect 1987;9:11-21.
7. Bingen E, Botzenhardt K, Chabanon G, et al. In: Doring G, Shaffer L, editors. Epidemiology of pulmonary infections by Pseudomonas in patients with cystic fibrosis: a consensus report. Paris: Association Francaise de lutte contre la Mucoviscidose; 1993.
8. Speert DP, Lawton D, Damm S. Communicability of Pseudomonas aeruginosa in a cystic fibrosis summer camp. J Pediatr 1982;101:227-229.
9. Hoogkamp-Korstanje JA, Meis JA, Kissing J, van der Laag J, Melchers JW. Risk of cross colonization and infection by Pseudomonas aeruginosa in a holiday camp for cystic fibrosis patients. J Clin Microbiol 1995;33:572-575.
10. Farrell PM, Shen G, Splaingard M, Colby CE, Laxova A, Kosorok MR, Rock MJ, Mischler EH. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics 1997;100(5):e2.
11. Frederiksen B, Koch C, Hoiby N. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr Pulmonol 1999;28:159-166.
12. Saiman L, Corey M. Further insights into early acquisition of Pseudomonas aeruginosa. Pediatr Pulmonol 1998;26:79-80.
13. Cheng K, Smyth RL, Govan JR, Doherty C, Winstanley C, Denning N, Heaf DP, van Saene H, Hart CA. Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996;348:639-642.
14. Jones AM, Govan JR, Doherty CJ, Dodd ME, Isalaka BJ, Stanbridge TN, Webb AK. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 2001;358:557-558.
15. McCallum SJ, Corkill J, Gallagher M, Ledson MJ. Hart CA, Walshaw MJ. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P. aeruginosa. Lancet 2001;358:558-560.
16. Spencer D. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross infection with Pseudomonas aeruginosa is unusual. BMJ 1999;318:58.
17. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Gutierrez JP, Hull J, Olinsky A, Phelan EM, Robertson CF, Phelan PD. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997;156:1197-1204.
18. Massie RJ, Olsen M, Glazner J, Robertson CF, Francis I. Newborn screening for cystic fibrosis in Victoria: 10 year's experience (1989-1998). Med J Aust 2000;172:584-587.
19. Phelan PD, Bowes G. Cystic fibrosis in Melbourne. Thorax 1991;46:383-384.
20. Taussig LM, Kattwinkel J, Friedewald WT, di Sant'Agnese PA. A new prognostic score and clinical evaluation system for cystic fibrosis. J Pediatr 1973;82:380-390.
21. Wahba AH, Darrell JH. The identification of atypical strains of Pseudomonas aeruginosa. J Gen Microbiol 1965;38:329-342.
22. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests: approved standard M2-A6. Wayne, PA: National Committee for Clinical Laboratory Standards; 1997.
23. Cystic Fibrosis Foundation. Microbiology and infectious diseases in cystic fibrosis. Consensus Conference: concepts in care, Vol. 5, section 1. Bethesda, MD: Cystic Fibrosis Foundation; 1994.
24. Armstrong DS, Grimwood K, Carzino R, Carlin JB, Olinsky A, Phelan PD. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol 1996;21:267-275.
25. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239.
26. Statacorp. Stata Statistical Software: Release 5.0. College Station, TX: Stata Corporation.
27. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001;138:699-704.
28. Da Silva Filho LVF, Levi JE, Bento CNO, Rodrigues JC, Da Silva Ramos SRT. Molecular epidemiology of Pseudomonas aeruginosa infections in a cystic fibrosis outpatient clinic. J Med Microbiol 2001;50:261-267.
29. Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 2001;183:444-452.
30. Pedersen SS, Koch C, Hoiby N, Rosendal K. An epidemic spread of a multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J Antimicrob Chemother 1986;17:505-516.
31. Mahadeva R, Webb K, Westerbeek RC, Carroll NR, Dodd ME, Bilton D, Lomas DA. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ 1998;316:1771-1775.
32. Armstrong D, Grimwood K, Carlin JB, Carzino R, Hull J, Olinsky A, Phelan PD. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr Pulmonol 1998;26:371-379.
33. Adams C, Morris-Quinn M, McConnell F, West J, Lucey B, Shortt C, Cryan B, Watson JB, O'Gara F. Epidemiology and clinical impact of Pseudomonas aeruginosa infection in cystic fibrosis using AP-PCR fingerprinting. J Infect 1998;37:151-158.
34. Williams T. Evaluation of antimicrobial sensitivity patterns as markers of Pseudomonas aeruginosa cross-infection at a cystic fibrosis clinic. Br J Biomed Sci 1997;54:181-185.
35. Geddes DM. Of isolates and isolation: Pseudomonas aeruginosa in adults with cystic fibrosis. Lancet 2001;358:522-523.